LUMBAR DISC HERNIATION
Overview
​
The current study is a Phase 3, multicenter, randomized, double-blind, sham-controlled,
comparative study of SI-6603 in subjects with LDH. Subjects will receive a single intradiscal
dose of SI-6603 1.25 U or a sham injection as control. Safety will be followed for 12 months
after investigational product administration.
Do you Qualify?
​These questions require a yes answer to qualify.​
​
-
Are you between 30 and 70 years of age?
​
-
Are you experiencing leg pain caused by the herniation?
​These questions require a no answer to qualify.​
​
-
Are you currently pregnant, plan to become pregnant or breastfeeding?
​
-
Currently suffering from any major illnesses that may require extended hospitalization?
​
-
In the past year have you suffered with any chronic drug or alcohol abuse?
​
​​
If you think you may be eligible for this trial, please give us a call to schedule an appointment or click button below to email a request.